L. Lepescheux

1.2k total citations
21 papers, 975 citations indexed

About

L. Lepescheux is a scholar working on Rheumatology, Oncology and Molecular Biology. According to data from OpenAlex, L. Lepescheux has authored 21 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in L. Lepescheux's work include Osteoarthritis Treatment and Mechanisms (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). L. Lepescheux is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). L. Lepescheux collaborates with scholars based in Belgium, France and Australia. L. Lepescheux's co-authors include Philippe Clément-Lacroix, Reginald Brys, Georges Rawadi, Enrico Bastianelli, Hai‐Shu Lin, Ching Yuan Hu, Roland Baron, Hsiao Yun Chan, N. Vandeghinste and Thierry Christophe and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Endocrinology.

In The Last Decade

L. Lepescheux

20 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Lepescheux Belgium	13	364	282	237	200	110	21	975
Atsuhiko Kato Japan	19	347 1.0×	228 0.8×	79 0.3×	234 1.2×	57 0.5×	71	1.0k
Majid Shahbazi Iran	13	463 1.3×	271 1.0×	73 0.3×	227 1.1×	95 0.9×	72	1.1k
Walter Conca Saudi Arabia	16	315 0.9×	201 0.7×	123 0.5×	123 0.6×	64 0.6×	42	983
Ebrahim Sakhinia Iran	22	681 1.9×	266 0.9×	121 0.5×	184 0.9×	71 0.6×	73	1.3k
Yenkel Grinberg‐Bleyer France	15	266 0.7×	345 1.2×	45 0.2×	966 4.8×	223 2.0×	26	1.4k
Dapeng Wang United States	19	494 1.4×	288 1.0×	55 0.2×	571 2.9×	102 0.9×	44	1.4k
Anastasia Chillà Italy	23	667 1.8×	265 0.9×	49 0.2×	234 1.2×	58 0.5×	45	1.1k
Lyle E. Pegg United States	11	431 1.2×	162 0.6×	63 0.3×	217 1.1×	103 0.9×	17	873
Terufumi Kubo Japan	20	477 1.3×	504 1.8×	72 0.3×	437 2.2×	46 0.4×	92	1.3k
Steven F. Ziegler United States	8	320 0.9×	506 1.8×	58 0.2×	528 2.6×	77 0.7×	11	1.3k

Countries citing papers authored by L. Lepescheux

Since Specialization

Citations

This map shows the geographic impact of L. Lepescheux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lepescheux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lepescheux more than expected).

Fields of papers citing papers by L. Lepescheux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Lepescheux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lepescheux. The network helps show where L. Lepescheux may publish in the future.

Co-authorship network of co-authors of L. Lepescheux

This figure shows the co-authorship network connecting the top 25 collaborators of L. Lepescheux. A scholar is included among the top collaborators of L. Lepescheux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Lepescheux. L. Lepescheux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Little, Christopher B., Margaret M. Smith, Patrick Mollat, et al.. (2021). Pharmacological characterization of GLPG1972/S201086, a potent and selective small-molecule inhibitor of ADAMTS5. Osteoarthritis and Cartilage. 30(2). 291–301. 22 indexed citations

Lauffer, Felix, Manja Jargosch, Linda Krause, et al.. (2019). IL‐17C amplifies epithelial inflammation in human psoriasis and atopic eczema. Journal of the European Academy of Dermatology and Venereology. 34(4). 800–809. 35 indexed citations

Vandeghinste, N., Florence Marsais, Jan D. Haas, et al.. (2018). Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis. Journal of Investigative Dermatology. 138(7). 1555–1563. 94 indexed citations

Lepescheux, L., Monica Borgonovi, Patrick Mollat, et al.. (2018). ADAMTS-5 inhibition with the potent and highly selective inhibitor GLPG1972 results in strong disease-modifying OA drug effects in the rat meniscectomy model. Osteoarthritis and Cartilage. 26. S26–S26. 4 indexed citations

Lepescheux, L., Monica Borgonovi, Patrick Mollat, et al.. (2018). OP0258 Efficacy of the highly selective adamts-5 inhibitor glpg1972 in the rat meniscectomy model. Annals of the Rheumatic Diseases. 77. 178–178. 3 indexed citations

Little, Christopher B., Roland Blanqué, Patrick Mollat, et al.. (2017). GLPG1972: a potent, selective, orally available adamts-5 inhibitor for the treatment of OA. Osteoarthritis and Cartilage. 25. S58–S59. 13 indexed citations

Clément-Lacroix, Philippe, Christopher B. Little, Roland Blanqué, et al.. (2017). OP0180 Pharmacological characterization of the ADAMTS-5 inhibitor GLPG1972: an oral anti-catabolic agent for the treatment of osteoarthritis. Annals of the Rheumatic Diseases. 76. 126–126. 1 indexed citations

Marsais, Florence, Annick Cauvin, Estelle Chanudet, et al.. (2017). OP0161 The JAK1 selective inhibitor filgotinib regulates both enthesis and colon inflammation in a mouse model of psoriatic arthritis. Annals of the Rheumatic Diseases. 76. 118–119. 5 indexed citations

Blanqué, Roland, L. Lepescheux, Marielle Auberval, et al.. (2014). Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization. BMC Musculoskeletal Disorders. 15(1). 291–291. 21 indexed citations

10.

Menet, Christel, Stephen R. Fletcher, Guy Van Lommen, et al.. (2014). Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634. Journal of Medicinal Chemistry. 57(22). 9323–9342. 93 indexed citations

11.

Rompaey, Luc Van, René Galien, Ellen M. van der Aar, et al.. (2013). Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases. The Journal of Immunology. 191(7). 3568–3577. 181 indexed citations

12.

Vayssière, Béatrice, Steve De Vos, Marielle Auberval, et al.. (2013). THU0116 Biological Effects of the JAK1 Selective Inhibitor GLPG0634 on Inflammation Markers in Arthritic Mice. Annals of the Rheumatic Diseases. 72. A201–A202.

13.

Jacques, Peggy, Jens Van Praet, Michael Drennan, et al.. (2010). A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Research & Therapy. 12(4). R160–R160. 61 indexed citations

14.

Lin, Hai‐Shu, Ching Yuan Hu, Hsiao Yun Chan, et al.. (2007). Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen‐induced arthritis in rodents. British Journal of Pharmacology. 150(7). 862–872. 225 indexed citations

15.

Windahl, Sara H., R. Galien, Riccardo Chiusaroli, et al.. (2006). Bone protection by estrens occurs through non–tissue-selective activation of the androgen receptor. Journal of Clinical Investigation. 116(9). 2500–2509. 18 indexed citations

16.

Lepescheux, L., et al.. (2001). Effects of 17β-estradiol and trimegestone alone ,and in combination ,on the bone and uterus of ovariectomized rats. Gynecological Endocrinology. 15(4). 312–320. 12 indexed citations

17.

Clément-Lacroix, Philippe, Christopher J. Ormandy, L. Lepescheux, et al.. (1999). Osteoblasts Are a New Target for Prolactin. Obstetrical & Gynecological Survey. 54(6). 383–384. 3 indexed citations

18.

Clément-Lacroix, Philippe, Christopher J. Ormandy, L. Lepescheux, et al.. (1999). Osteoblasts Are a New Target for Prolactin: Analysis of Bone Formation in Prolactin Receptor Knockout Mice**This work was supported in part by grants from Hoechst Marion Roussel, Inc.. Endocrinology. 140(1). 96–105. 152 indexed citations

19.

Gaill, Françoise, D. Herbage, & L. Lepescheux. (1991). A Discrete Helicoid of Collagenous Fibrils: The Cuticle of Deep-Sea Hydrothermal Vent Worms (Riftia pachyptila). Matrix. 11(3). 197–205. 8 indexed citations

20.

Gaill, Françoise, D. Herbage, & L. Lepescheux. (1988). Cuticle structure and composition of two invertebrates of hydrothermal vents: Alvinella pompejana and Riftia pachyptila. Institutional Archive of Ifremer (French Research Institute for Exploitation of the Sea). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact